1 Market Overview 1.1 Product Overview and Scope of Targeted Drugs for Colorectal Cancer 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Targeted Drugs for Colorectal Cancer Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 EGFR Target 1.3.3 BRAF Target 1.3.4 MEK1/2 Targets 1.3.5 BRAF V600 Target 1.3.6 HER2 Target 1.3.7 VEGFR-1/2/3 Targets 1.3.8 PD-1 Target 1.3.9 CTLA-4 Target 1.4 Market Analysis by Application 1.4.1 Overview: Global Targeted Drugs for Colorectal Cancer Consumption Value by Application: 2018 Versus 2022 Versus 2029 1.4.2 Hospital 1.4.3 Specialty Clinic 1.5 Global Targeted Drugs for Colorectal Cancer Market Size & Forecast 1.5.1 Global Targeted Drugs for Colorectal Cancer Consumption Value (2018 & 2022 & 2029) 1.5.2 Global Targeted Drugs for Colorectal Cancer Sales Quantity (2018-2029) 1.5.3 Global Targeted Drugs for Colorectal Cancer Average Price (2018-2029) 2 Manufacturers Profiles 2.1 Merck 2.1.1 Merck Details 2.1.2 Merck Major Business 2.1.3 Merck Targeted Drugs for Colorectal Cancer Product and Services 2.1.4 Merck Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.1.5 Merck Recent Developments/Updates 2.2 Amgen 2.2.1 Amgen Details 2.2.2 Amgen Major Business 2.2.3 Amgen Targeted Drugs for Colorectal Cancer Product and Services 2.2.4 Amgen Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.2.5 Amgen Recent Developments/Updates 2.3 F. Hoffmann-La Roche Ltd 2.3.1 F. Hoffmann-La Roche Ltd Details 2.3.2 F. Hoffmann-La Roche Ltd Major Business 2.3.3 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services 2.3.4 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates 2.4 Novartis 2.4.1 Novartis Details 2.4.2 Novartis Major Business 2.4.3 Novartis Targeted Drugs for Colorectal Cancer Product and Services 2.4.4 Novartis Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.4.5 Novartis Recent Developments/Updates 2.5 Array BioPharma 2.5.1 Array BioPharma Details 2.5.2 Array BioPharma Major Business 2.5.3 Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services 2.5.4 Array BioPharma Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.5.5 Array BioPharma Recent Developments/Updates 2.6 Genentech 2.6.1 Genentech Details 2.6.2 Genentech Major Business 2.6.3 Genentech Targeted Drugs for Colorectal Cancer Product and Services 2.6.4 Genentech Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.6.5 Genentech Recent Developments/Updates 2.7 Bayer 2.7.1 Bayer Details 2.7.2 Bayer Major Business 2.7.3 Bayer Targeted Drugs for Colorectal Cancer Product and Services 2.7.4 Bayer Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.7.5 Bayer Recent Developments/Updates 2.8 Sanofi 2.8.1 Sanofi Details 2.8.2 Sanofi Major Business 2.8.3 Sanofi Targeted Drugs for Colorectal Cancer Product and Services 2.8.4 Sanofi Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.8.5 Sanofi Recent Developments/Updates 2.9 Lilly 2.9.1 Lilly Details 2.9.2 Lilly Major Business 2.9.3 Lilly Targeted Drugs for Colorectal Cancer Product and Services 2.9.4 Lilly Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.9.5 Lilly Recent Developments/Updates 2.10 Bristol myers squibb 2.10.1 Bristol myers squibb Details 2.10.2 Bristol myers squibb Major Business 2.10.3 Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services 2.10.4 Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.10.5 Bristol myers squibb Recent Developments/Updates 2.11 MSD lreland 2.11.1 MSD lreland Details 2.11.2 MSD lreland Major Business 2.11.3 MSD lreland Targeted Drugs for Colorectal Cancer Product and Services 2.11.4 MSD lreland Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.11.5 MSD lreland Recent Developments/Updates 2.12 HUTCHMED 2.12.1 HUTCHMED Details 2.12.2 HUTCHMED Major Business 2.12.3 HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services 2.12.4 HUTCHMED Targeted Drugs for Colorectal Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023) 2.12.5 HUTCHMED Recent Developments/Updates 3 Competitive Environment: Targeted Drugs for Colorectal Cancer by Manufacturer 3.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Manufacturer (2018-2023) 3.2 Global Targeted Drugs for Colorectal Cancer Revenue by Manufacturer (2018-2023) 3.3 Global Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023) 3.4 Market Share Analysis (2022) 3.4.1 Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2022 3.4.2 Top 3 Targeted Drugs for Colorectal Cancer Manufacturer Market Share in 2022 3.4.2 Top 6 Targeted Drugs for Colorectal Cancer Manufacturer Market Share in 2022 3.5 Targeted Drugs for Colorectal Cancer Market: Overall Company Footprint Analysis 3.5.1 Targeted Drugs for Colorectal Cancer Market: Region Footprint 3.5.2 Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint 3.5.3 Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint 3.6 New Market Entrants and Barriers to Market Entry 3.7 Mergers, Acquisition, Agreements, and Collaborations 4 Consumption Analysis by Region 4.1 Global Targeted Drugs for Colorectal Cancer Market Size by Region 4.1.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2029) 4.1.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2029) 4.1.3 Global Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2029) 4.2 North America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) 4.3 Europe Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) 4.4 Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) 4.5 South America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) 4.6 Middle East and Africa Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) 5 Market Segment by Type 5.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029) 5.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2018-2029) 5.3 Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029) 6 Market Segment by Application 6.1 Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029) 6.2 Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2018-2029) 6.3 Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029) 7 North America 7.1 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029) 7.2 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029) 7.3 North America Targeted Drugs for Colorectal Cancer Market Size by Country 7.3.1 North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029) 7.3.2 North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029) 7.3.3 United States Market Size and Forecast (2018-2029) 7.3.4 Canada Market Size and Forecast (2018-2029) 7.3.5 Mexico Market Size and Forecast (2018-2029) 8 Europe 8.1 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029) 8.2 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029) 8.3 Europe Targeted Drugs for Colorectal Cancer Market Size by Country 8.3.1 Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029) 8.3.2 Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029) 8.3.3 Germany Market Size and Forecast (2018-2029) 8.3.4 France Market Size and Forecast (2018-2029) 8.3.5 United Kingdom Market Size and Forecast (2018-2029) 8.3.6 Russia Market Size and Forecast (2018-2029) 8.3.7 Italy Market Size and Forecast (2018-2029) 9 Asia-Pacific 9.1 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029) 9.2 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029) 9.3 Asia-Pacific Targeted Drugs for Colorectal Cancer Market Size by Region 9.3.1 Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2029) 9.3.2 Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2029) 9.3.3 China Market Size and Forecast (2018-2029) 9.3.4 Japan Market Size and Forecast (2018-2029) 9.3.5 Korea Market Size and Forecast (2018-2029) 9.3.6 India Market Size and Forecast (2018-2029) 9.3.7 Southeast Asia Market Size and Forecast (2018-2029) 9.3.8 Australia Market Size and Forecast (2018-2029) 10 South America 10.1 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029) 10.2 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029) 10.3 South America Targeted Drugs for Colorectal Cancer Market Size by Country 10.3.1 South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029) 10.3.2 South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029) 10.3.3 Brazil Market Size and Forecast (2018-2029) 10.3.4 Argentina Market Size and Forecast (2018-2029) 11 Middle East & Africa 11.1 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2029) 11.2 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2029) 11.3 Middle East & Africa Targeted Drugs for Colorectal Cancer Market Size by Country 11.3.1 Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2029) 11.3.2 Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2029) 11.3.3 Turkey Market Size and Forecast (2018-2029) 11.3.4 Egypt Market Size and Forecast (2018-2029) 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029) 11.3.6 South Africa Market Size and Forecast (2018-2029) 12 Market Dynamics 12.1 Targeted Drugs for Colorectal Cancer Market Drivers 12.2 Targeted Drugs for Colorectal Cancer Market Restraints 12.3 Targeted Drugs for Colorectal Cancer Trends Analysis 12.4 Porters Five Forces Analysis 12.4.1 Threat of New Entrants 12.4.2 Bargaining Power of Suppliers 12.4.3 Bargaining Power of Buyers 12.4.4 Threat of Substitutes 12.4.5 Competitive Rivalry 12.5 Influence of COVID-19 and Russia-Ukraine War 12.5.1 Influence of COVID-19 12.5.2 Influence of Russia-Ukraine War 13 Raw Material and Industry Chain 13.1 Raw Material of Targeted Drugs for Colorectal Cancer and Key Manufacturers 13.2 Manufacturing Costs Percentage of Targeted Drugs for Colorectal Cancer 13.3 Targeted Drugs for Colorectal Cancer Production Process 13.4 Targeted Drugs for Colorectal Cancer Industrial Chain 14 Shipments by Distribution Channel 14.1 Sales Channel 14.1.1 Direct to End-User 14.1.2 Distributors 14.2 Targeted Drugs for Colorectal Cancer Typical Distributors 14.3 Targeted Drugs for Colorectal Cancer Typical Customers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology 16.2 Research Process and Data Source 16.3 Disclaimer

List of Tables Table 1. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029 Table 2. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application, (USD Million), 2018 & 2022 & 2029 Table 3. Merck Basic Information, Manufacturing Base and Competitors Table 4. Merck Major Business Table 5. Merck Targeted Drugs for Colorectal Cancer Product and Services Table 6. Merck Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 7. Merck Recent Developments/Updates Table 8. Amgen Basic Information, Manufacturing Base and Competitors Table 9. Amgen Major Business Table 10. Amgen Targeted Drugs for Colorectal Cancer Product and Services Table 11. Amgen Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 12. Amgen Recent Developments/Updates Table 13. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors Table 14. F. Hoffmann-La Roche Ltd Major Business Table 15. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services Table 16. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 17. F. Hoffmann-La Roche Ltd Recent Developments/Updates Table 18. Novartis Basic Information, Manufacturing Base and Competitors Table 19. Novartis Major Business Table 20. Novartis Targeted Drugs for Colorectal Cancer Product and Services Table 21. Novartis Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 22. Novartis Recent Developments/Updates Table 23. Array BioPharma Basic Information, Manufacturing Base and Competitors Table 24. Array BioPharma Major Business Table 25. Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services Table 26. Array BioPharma Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 27. Array BioPharma Recent Developments/Updates Table 28. Genentech Basic Information, Manufacturing Base and Competitors Table 29. Genentech Major Business Table 30. Genentech Targeted Drugs for Colorectal Cancer Product and Services Table 31. Genentech Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 32. Genentech Recent Developments/Updates Table 33. Bayer Basic Information, Manufacturing Base and Competitors Table 34. Bayer Major Business Table 35. Bayer Targeted Drugs for Colorectal Cancer Product and Services Table 36. Bayer Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 37. Bayer Recent Developments/Updates Table 38. Sanofi Basic Information, Manufacturing Base and Competitors Table 39. Sanofi Major Business Table 40. Sanofi Targeted Drugs for Colorectal Cancer Product and Services Table 41. Sanofi Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 42. Sanofi Recent Developments/Updates Table 43. Lilly Basic Information, Manufacturing Base and Competitors Table 44. Lilly Major Business Table 45. Lilly Targeted Drugs for Colorectal Cancer Product and Services Table 46. Lilly Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 47. Lilly Recent Developments/Updates Table 48. Bristol myers squibb Basic Information, Manufacturing Base and Competitors Table 49. Bristol myers squibb Major Business Table 50. Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services Table 51. Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 52. Bristol myers squibb Recent Developments/Updates Table 53. MSD lreland Basic Information, Manufacturing Base and Competitors Table 54. MSD lreland Major Business Table 55. MSD lreland Targeted Drugs for Colorectal Cancer Product and Services Table 56. MSD lreland Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 57. MSD lreland Recent Developments/Updates Table 58. HUTCHMED Basic Information, Manufacturing Base and Competitors Table 59. HUTCHMED Major Business Table 60. HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services Table 61. HUTCHMED Targeted Drugs for Colorectal Cancer Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023) Table 62. HUTCHMED Recent Developments/Updates Table 63. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Manufacturer (2018-2023) & (K Units) Table 64. Global Targeted Drugs for Colorectal Cancer Revenue by Manufacturer (2018-2023) & (USD Million) Table 65. Global Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023) & (US$/Unit) Table 66. Market Position of Manufacturers in Targeted Drugs for Colorectal Cancer, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022 Table 67. Head Office and Targeted Drugs for Colorectal Cancer Production Site of Key Manufacturer Table 68. Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint Table 69. Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint Table 70. Targeted Drugs for Colorectal Cancer New Market Entrants and Barriers to Market Entry Table 71. Targeted Drugs for Colorectal Cancer Mergers, Acquisition, Agreements, and Collaborations Table 72. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units) Table 73. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units) Table 74. Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million) Table 75. Global Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million) Table 76. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2023) & (US$/Unit) Table 77. Global Targeted Drugs for Colorectal Cancer Average Price by Region (2024-2029) & (US$/Unit) Table 78. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units) Table 79. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units) Table 80. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2018-2023) & (USD Million) Table 81. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type (2024-2029) & (USD Million) Table 82. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2023) & (US$/Unit) Table 83. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2024-2029) & (US$/Unit) Table 84. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units) Table 85. Global Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units) Table 86. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2018-2023) & (USD Million) Table 87. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application (2024-2029) & (USD Million) Table 88. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2023) & (US$/Unit) Table 89. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2024-2029) & (US$/Unit) Table 90. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units) Table 91. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units) Table 92. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units) Table 93. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units) Table 94. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units) Table 95. North America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units) Table 96. North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million) Table 97. North America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million) Table 98. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units) Table 99. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units) Table 100. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units) Table 101. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units) Table 102. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units) Table 103. Europe Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units) Table 104. Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million) Table 105. Europe Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million) Table 106. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units) Table 107. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units) Table 108. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units) Table 109. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units) Table 110. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units) Table 111. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units) Table 112. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million) Table 113. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million) Table 114. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units) Table 115. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units) Table 116. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units) Table 117. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units) Table 118. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2018-2023) & (K Units) Table 119. South America Targeted Drugs for Colorectal Cancer Sales Quantity by Country (2024-2029) & (K Units) Table 120. South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2018-2023) & (USD Million) Table 121. South America Targeted Drugs for Colorectal Cancer Consumption Value by Country (2024-2029) & (USD Million) Table 122. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2018-2023) & (K Units) Table 123. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Type (2024-2029) & (K Units) Table 124. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2018-2023) & (K Units) Table 125. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Application (2024-2029) & (K Units) Table 126. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2018-2023) & (K Units) Table 127. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity by Region (2024-2029) & (K Units) Table 128. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Region (2018-2023) & (USD Million) Table 129. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value by Region (2024-2029) & (USD Million) Table 130. Targeted Drugs for Colorectal Cancer Raw Material Table 131. Key Manufacturers of Targeted Drugs for Colorectal Cancer Raw Materials Table 132. Targeted Drugs for Colorectal Cancer Typical Distributors Table 133. Targeted Drugs for Colorectal Cancer Typical Customers List of Figures Figure 1. Targeted Drugs for Colorectal Cancer Picture Figure 2. Global Targeted Drugs for Colorectal Cancer Consumption Value by Type, (USD Million), 2018 & 2022 & 2029 Figure 3. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Type in 2022 Figure 4. EGFR Target Examples Figure 5. BRAF Target Examples Figure 6. MEK1/2 Targets Examples Figure 7. BRAF V600 Target Examples Figure 8. HER2 Target Examples Figure 9. VEGFR-1/2/3 Targets Examples Figure 10. PD-1 Target Examples Figure 11. CTLA-4 Target Examples Figure 12. Global Targeted Drugs for Colorectal Cancer Consumption Value by Application, (USD Million), 2018 & 2022 & 2029 Figure 13. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Application in 2022 Figure 14. Hospital Examples Figure 15. Specialty Clinic Examples Figure 16. Global Targeted Drugs for Colorectal Cancer Consumption Value, (USD Million): 2018 & 2022 & 2029 Figure 17. Global Targeted Drugs for Colorectal Cancer Consumption Value and Forecast (2018-2029) & (USD Million) Figure 18. Global Targeted Drugs for Colorectal Cancer Sales Quantity (2018-2029) & (K Units) Figure 19. Global Targeted Drugs for Colorectal Cancer Average Price (2018-2029) & (US$/Unit) Figure 20. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Manufacturer in 2022 Figure 21. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Manufacturer in 2022 Figure 22. Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021 Figure 23. Top 3 Targeted Drugs for Colorectal Cancer Manufacturer (Consumption Value) Market Share in 2022 Figure 24. Top 6 Targeted Drugs for Colorectal Cancer Manufacturer (Consumption Value) Market Share in 2022 Figure 25. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029) Figure 26. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029) Figure 27. North America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million) Figure 28. Europe Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million) Figure 29. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million) Figure 30. South America Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million) Figure 31. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value (2018-2029) & (USD Million) Figure 32. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029) Figure 33. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Type (2018-2029) Figure 34. Global Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029) & (US$/Unit) Figure 35. Global Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029) Figure 36. Global Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Application (2018-2029) Figure 37. Global Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029) & (US$/Unit) Figure 38. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029) Figure 39. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029) Figure 40. North America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029) Figure 41. North America Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029) Figure 42. United States Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 43. Canada Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 44. Mexico Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 45. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029) Figure 46. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029) Figure 47. Europe Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029) Figure 48. Europe Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029) Figure 49. Germany Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 50. France Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 51. United Kingdom Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 52. Russia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 53. Italy Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 54. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029) Figure 55. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029) Figure 56. Asia-Pacific Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029) Figure 57. Asia-Pacific Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029) Figure 58. China Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 59. Japan Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 60. Korea Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 61. India Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 62. Southeast Asia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 63. Australia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 64. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029) Figure 65. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029) Figure 66. South America Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Country (2018-2029) Figure 67. South America Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Country (2018-2029) Figure 68. Brazil Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 69. Argentina Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 70. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Type (2018-2029) Figure 71. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Application (2018-2029) Figure 72. Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Quantity Market Share by Region (2018-2029) Figure 73. Middle East & Africa Targeted Drugs for Colorectal Cancer Consumption Value Market Share by Region (2018-2029) Figure 74. Turkey Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 75. Egypt Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 76. Saudi Arabia Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 77. South Africa Targeted Drugs for Colorectal Cancer Consumption Value and Growth Rate (2018-2029) & (USD Million) Figure 78. Targeted Drugs for Colorectal Cancer Market Drivers Figure 79. Targeted Drugs for Colorectal Cancer Market Restraints Figure 80. Targeted Drugs for Colorectal Cancer Market Trends Figure 81. Porters Five Forces Analysis Figure 82. Manufacturing Cost Structure Analysis of Targeted Drugs for Colorectal Cancer in 2022 Figure 83. Manufacturing Process Analysis of Targeted Drugs for Colorectal Cancer Figure 84. Targeted Drugs for Colorectal Cancer Industrial Chain Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors Figure 86. Direct Channel Pros & Cons Figure 87. Indirect Channel Pros & Cons Figure 88. Methodology Figure 89. Research Process and Data Source

Merck Amgen F. Hoffmann-La Roche Ltd Novartis Array BioPharma Genentech Bayer Sanofi Lilly Bristol myers squibb MSD lreland HUTCHMED